HSBC is cutting its U.S. debt capital markets team, reflecting a strategic withdrawal from certain Western financial markets to reduce costs. This creates an investment opportunity centered on U.S.-focused investment banks and financial firms that stand to gain market share from the retreat of global competitors.
Published on February 20
As major competitors withdraw from U.S. markets, these firms are positioned to capture increased deal flow and client relationships that could boost revenues significantly.
Fewer players in the debt capital markets means less competition for lucrative underwriting deals and advisory mandates, potentially improving profit margins for remaining firms.
These companies have strong domestic operations and established client bases, making them natural beneficiaries when international banks scale back their U.S. presence.
As major international banks like HSBC withdraw from U.S. debt capital markets, domestic financial institutions are positioned to capture greater market share. This strategic shift creates opportunities for established U.S. banks and financial services firms that maintain strong domestic operations and can absorb clients and deal flow from retreating competitors.
This group includes investment banks, asset managers, brokerages, and financial service providers across the value chain. These firms operate primarily in the U.S. market and have the infrastructure to handle increased business volumes. The theme focuses on companies that can directly benefit from reduced competition in debt underwriting, advisory services, and client relationships.
These stocks were handpicked by professional analysts based on their strong U.S. market presence and ability to absorb market share from international competitors scaling back operations. Each company has established client relationships, proven expertise, and the operational capacity to benefit from this competitive landscape shift in financial services.
The basket's total market capitalisation is $NaN and is anchored by large-cap stocks, which generally give it a more stable, lower-risk profile.
GS: $274.93B
MS: $276.03B
JEF: $10.99B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+5
Here are a few of the assets in this group. Create an account to unlock the full list.
GS
GS
Current Price
$1,029.18
As a leading U.S. investment bank, Goldman Sachs is well-positioned to absorb market share in the debt capital markets following a major competitor's ...
As a leading U.S. investment bank, Goldman Sachs is well-positioned to absorb market share in the debt capital markets following a major competitor's withdrawal.
Join Nemo FREE today and unlock every stock
It only takes 60 seconds.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+12.26%
On average, analysts expect assets in this group to grow 12.26% over the next year.
11 of 14 assets in this group are rated Buy by professional analysts.
